Risk and prognostic significance of metachronous contralateral testicular germ cell tumours

被引：0
作者：
M Schaapveld
A W van den Belt-Dusebout
J A Gietema
R de Wit
S Horenblas
J A Witjes
H J Hoekstra
L A L M Kiemeney
W J Louwman
G M Ouwens
B M P Aleman
F E van Leeuwen
机构：
[1] the Netherlands Cancer Institute,Department of Psychosocial Research and Epidemiology
[2] Comprehensive Cancer Center,Department of Medical Oncology
[3] The Netherlands,Department of Medical Oncology
[4] University Medical Center Groningen,Department of Urology
[5] Erasmus Medical Center-Daniel den Hoed Cancer Center,Department of Urology
[6] the Netherlands Cancer Institute,Department of Surgical Oncology
[7] Radboud University Medical Center,Department of Urology and Epidemiology
[8] Nijmegen,Department of Radiotherapy
[9] University Medical Center Groningen,undefined
[10] Radboud University Medical Center,undefined
[11] Comprehensive Cancer Center South,undefined
[12] the Netherlands Cancer Institute,undefined
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
contralateral testicular germ cell tumour; chemotherapy; platinum; cumulative incidence; prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1637 / 1643
页数：6
相关论文
共 105 条
[1]  
Andreassen KE(2011)Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953–2007) Int J Cancer 129 2867-2874
[2]  
Grotmol T(2010)Fitting additive Poisson models Epidemiol Perspect Innov 7 4-1233
[3]  
Cvancarova MS(2002)Bilateral testicular germ cell tumors: twenty-year experience at M. D. Anderson Cancer Center Cancer 95 1228-1144
[4]  
Johannesen TB(2002)Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data Stat Med 21 1129-660
[5]  
Fosså SD(1998)Effect of chemotherapy on carcinoma Ann Oncol 9 657-183
[6]  
Boshuizen HC(2007) of the testis Eur Urol 51 175-509
[7]  
Feskens EJ(1999)Diagnosis of contralateral testicular intraepithelial neoplasia (TIN) in patients with testicular germ cell cancer: systematic two-site biopsies are more sensitive than a single random biopsy J Amer Statist Assoc 94 496-1066
[8]  
Che M(2005)A proportional hazards model for the subdistribution of a competing risk J Natl Cancer Inst 97 1056-706
[9]  
Tamboli P(1999)Risk of contralateral testicular cancer: a population-based study of 29,515 U.S. men Stat Med 18 695-1027
[10]  
Ro JY(1984)Estimation of failure probabilities in the presence of competing risks: new representations of old estimators J Clin Oncol 2 1025-536
12345678910